188 related articles for article (PubMed ID: 19456838)
1. Detection of AmpC beta-lactamases in Escherichia coli, Klebsiella spp., Salmonella spp. and Proteus mirabilis in a regional clinical microbiology laboratory.
Pitout JD; Le PG; Moore KL; Church DL; Gregson DB
Clin Microbiol Infect; 2010 Feb; 16(2):165-70. PubMed ID: 19456838
[TBL] [Abstract][Full Text] [Related]
2. Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extended-spectrum beta-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis.
Song W; Jeong SH; Kim JS; Kim HS; Shin DH; Roh KH; Lee KM
Diagn Microbiol Infect Dis; 2007 Mar; 57(3):315-8. PubMed ID: 17174510
[TBL] [Abstract][Full Text] [Related]
3. Inhibitor-based methods for detection of plasmid-mediated AmpC beta-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis.
Coudron PE
J Clin Microbiol; 2005 Aug; 43(8):4163-7. PubMed ID: 16081966
[TBL] [Abstract][Full Text] [Related]
4. Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
Tan TY; Ng SY; Teo L; Koh Y; Teok CH
J Clin Pathol; 2008 May; 61(5):642-4. PubMed ID: 18057079
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of beta-lactamase inhibitors in disk tests for detection of plasmid-mediated AmpC beta-lactamases in well-characterized clinical strains of Klebsiella spp.
Black JA; Thomson KS; Buynak JD; Pitout JD
J Clin Microbiol; 2005 Aug; 43(8):4168-71. PubMed ID: 16081967
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 3 phenotypic-detection methods for identifying plasmid-mediated AmpC beta-lactamase-producing Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis strains.
Lee W; Jung B; Hong SG; Song W; Jeong SH; Lee K; Kwak HS
Korean J Lab Med; 2009 Oct; 29(5):448-54. PubMed ID: 19893354
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and resistance patterns of extended-spectrum and AmpC β-lactamase in Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Salmonella serovar Stanley in a Korean tertiary hospital.
Park SD; Uh Y; Lee G; Lim K; Kim JB; Jeong SH
APMIS; 2010 Oct; 118(10):801-8. PubMed ID: 20854475
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the MicroScan NegCombo panel Type 44 for detection of extended-spectrum beta-lactamase among clinical isolates of Escherichia coli, Klebsiella species, and Proteus mirabilis].
Ko SY; Chung JW; Song AJ; Yoon NS; Sung H; Kim MN
Korean J Lab Med; 2009 Feb; 29(1):35-40. PubMed ID: 19262076
[TBL] [Abstract][Full Text] [Related]
9. [Investigation of plasmid-mediated AmpC beta-lactamase types in Klebsiella spp. and Escherichia coli isolates resistant or intermediate to cefoxitin].
Demirbakan H; Midilli K; Oğünç D; Ozen N; Ongüt G; Dağlar D; Mutlu D; Ozhak B; Colak D
Mikrobiyol Bul; 2008 Oct; 42(4):545-51. PubMed ID: 19149075
[TBL] [Abstract][Full Text] [Related]
10. Convenient test using a combination of chelating agents for detection of metallo-beta-lactamases in the clinical laboratory.
Kim SY; Hong SG; Moland ES; Thomson KS
J Clin Microbiol; 2007 Sep; 45(9):2798-801. PubMed ID: 17596358
[TBL] [Abstract][Full Text] [Related]
11. AmpC beta-lactamase producing multidrug resistant strains of Klebsiella spp. & Escherichia coli isolated from children under five in Chennai.
Subha A; Devi VR; Ananthan S
Indian J Med Res; 2003 Jan; 117():13-8. PubMed ID: 12866821
[TBL] [Abstract][Full Text] [Related]
12. Detection of extended-spectrum beta-lactamases by using boronic acid as an AmpC beta-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli.
Song W; Bae IK; Lee YN; Lee CH; Lee SH; Jeong SH
J Clin Microbiol; 2007 Apr; 45(4):1180-4. PubMed ID: 17301276
[TBL] [Abstract][Full Text] [Related]
13. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
J Infect Dev Ctries; 2009 May; 3(4):285-94. PubMed ID: 19759492
[TBL] [Abstract][Full Text] [Related]
14. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
J Infect Dev Ctries; 2009 Apr; 3(3):177-86. PubMed ID: 19759472
[TBL] [Abstract][Full Text] [Related]
15. [CMY-2-type plasmid-mediated AmpC ß-lactamases emerging in Tucumán, Argentina].
Jure MA; Presti C; Cudmani NM; Grellet LM; López C; Musa EH; Aulet OC; Nieto C; Saavedra L; de Castillo MC
Rev Argent Microbiol; 2011; 43(1):24-7. PubMed ID: 21491062
[TBL] [Abstract][Full Text] [Related]
16. [Detection of plasmid-mediated AmpC beta-lactamase in clinical isolates of cefoxitin-resistant Escherichia coli and Klebsiella pneumoniae].
Coşkun S; Altanlar N
Mikrobiyol Bul; 2012 Jul; 46(3):375-85. PubMed ID: 22951650
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic and molecular characterization of plasmid mediated AmpC β-lactamases among Escherichia coli, Klebsiella spp., and Proteus mirabilis isolated from urinary tract infections in Egyptian hospitals.
Helmy MM; Wasfi R
Biomed Res Int; 2014; 2014():171548. PubMed ID: 25003107
[TBL] [Abstract][Full Text] [Related]
18. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
Susić E
Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of screening methods to detect plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis.
Tan TY; Ng LS; He J; Koh TH; Hsu LY
Antimicrob Agents Chemother; 2009 Jan; 53(1):146-9. PubMed ID: 18955528
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of phenotypic screening methods for detecting plasmid-mediated AmpC beta-lactamases-producing isolates of Escherichia coli and Klebsiella pneumoniae.
Lee K; Hong SG; Park YJ; Lee HS; Song W; Jeong J; Yong D; Chong Y
Diagn Microbiol Infect Dis; 2005 Dec; 53(4):319-23. PubMed ID: 16269222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
